Skip to main content

Ransomware victim disclosure

All victims

Crystal Pharmatech

Claimed by Eclipse · listed 18 hours ago

Today
Age
since listed · data leaked

Status timeline

  1. ListedAug 23, 2026
  2. Data leakeddate unknown

At a glance

Group
Eclipse
Status
Data leaked
Listed on leak site
Aug 23, 2026

About the victim

AI dossier — public-source company profile

Crystal Pharmatech is a technology-driven CDMO/CRO established in 2010 that specializes in materials science, formulation development, and drug manufacturing services. With R&D and manufacturing centers across Suzhou, New Jersey, San Francisco, and Toronto, the company serves the pharmaceutical industry with services including API solid-state research, crystallization, preformulation, formulation development, clinical supply, and biologics services.

Industry
Contract Research Organization (CRO) / Contract Development and Manufacturing Organization (CDMO) — Pharmaceutical
Address
Multiple locations: Suzhou (China), New Jersey (USA), San Francisco (USA), Toronto (Canada)
Founded
2010

Attack summary

Severity: medium — Data has been published by the threat actor and the company operates in a regulated sector (pharmaceuticals) handling potentially sensitive R&D and manufacturing information, but the leak post provides no inventory of compromised data or proof files, limiting confidence in the breach scope.

Eclipse claims to have breached Crystal Pharmatech and published data. The leak post does not specify what data was exfiltrated, the nature of the attack (encryption vs. exfiltration or both), or the scope of affected information.

medium

What the group claims

Crystal Pharmatech is a technology-driven contract research organization (CRO) that focuses on materials science and engineering for drug development. Established in 2010 and have R&D centers located in Suzhou (China), New Jersey, San Francisco (USA), and Toronto (Canada). Also its key differentiator is integrated and specialized services, including API solid-state research, crystallization, preformulation, formulation development and manufacturing, clinical supply.

Sources

Source

Indexed 18 hours ago

This page surfaces a public ransomware disclosure indexed by Darkfield. Original posts come from the operator's own leak site; we cross-check against ransomware.live, RansomLook and RansomWatch where applicable. Share this URL freely.

Is this your supplier? Your competitor? You?

Pro plans monitor your domain, corporate emails, and crypto wallets across every new ransomware leak-site post, breach dump and Telegram callout — alerts within 5 minutes.

Disclosure context

About ECLIPSE

ECLIPSE is a ransomware operator currently tracked by Darkfield. The operation is currently active.

Timeline of this disclosure

  • August 23, 2026Crystal Pharmatech listed by ECLIPSEon the group's public leak site

Other recent disclosures by ECLIPSE

ECLIPSE has been linked to 0 public victims on Darkfield. A sample of the most recent:

See the full ECLIPSE dossier →

Sector and geography

This disclosure adds to ransomware activity in the Healthcare sector, which has 2,608 disclosures indexed across all operators we track. Geographically, Crystal Pharmatech is reported in United States, a country with 3,164 ransomware disclosures in our corpus.

If your organisation is affected

A listing by ECLIPSE means Crystal Pharmatech appeared on a ransomware extortion site and data attributed to it has been published. If this is your organisation, or a supplier you depend on, the priority is to confirm the intrusion and contain it before the window to act closes.

  • Engage your incident-response team and preserve forensic evidence before remediating — do not wipe affected systems first.
  • Force a password reset and revoke active sessions for exposed accounts; rotate any credentials, API keys or certificates that may have been in the stolen data.
  • Assess regulatory notification duties (GDPR, NIS2, sector regulators) — many carry a 72-hour reporting clock from awareness.
  • Report the incident to your national CERT, CISA (United States), as required for your jurisdiction.
  • Monitor for the data appearing on ECLIPSE's leak site and across paste and breach channels, and brief downstream partners who may be exposed through you.

How we know this. Darkfield monitors public ransomware leak sites continuously, archiving every new disclosure and the data later released against the victim. Each entry on this page is sourced from the operator's own publication and cross-checked against complementary OSINT feeds (RansomLook, ransomware.live, RansomWatch). We do not collect or host stolen data — only the metadata, timestamps and screenshots needed to make the public disclosure searchable and accountable. Records here are corrected when the original post is edited, retracted, or merged with another disclosure.